Scarica l'app Stockscreener
0.34
2.83%
-0.0099
Precedente Chiudi:
$0.3499
Aprire:
$0.3538
Volume 24 ore:
16,664
Relative Volume:
0.01
Capitalizzazione di mercato:
$30.23M
Reddito:
$8.90M
Utile/perdita netta:
$-4.57M
Rapporto P/E:
-6.1151
EPS:
-0.0556
Flusso di cassa netto:
$-1.84M
1 W Prestazione:
+5.92%
1M Prestazione:
-18.13%
6M Prestazione:
+18.47%
1 anno Prestazione:
-50.00%
Intervallo 1D:
$0.3374
$0.3538
Intervallo di 1 settimana:
$0.3308
$0.355
Portata 52W:
$0.2181
$0.7284
Milestone Scientific Inc. Stock (MLSS) Company Profile
Nome
Milestone Scientific Inc.
Settore
Industria
Telefono
973-535-2717
Indirizzo
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
0.3418 | 30.95M | 8.90M | -4.57M | -1.84M | -0.0556 |
ISRG
Intuitive Surgical Inc
|
426.39 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.35 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.98 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.01 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.60 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-09-16 | Iniziato | Northland Capital | Market Perform |
| 2018-11-16 | Reiterato | Maxim Group | Buy |
| 2016-12-23 | Reiterato | Maxim Group | Buy |
| 2015-12-11 | Iniziato | Maxim Group | Buy |
Milestone Scientific Inc. Borsa (MLSS) Ultime notizie
Milestone Scientific expects Q2 revenue of $2.8M - MSN
Price to sales forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
MLSSMilestone Scientific Inc Dividends - Finviz
Benchmark reiterates Milestone Scientific stock Speculative Buy on Q2 beat By Investing.com - Investing.com Nigeria
MLSS News | MILESTONE SCIENTIFIC INC (NYSEARCA:MLSS) - ChartMill
Milestone Scientific expects Q2 revenue of ~$2.8M, up 21% YoY - scanx.trade
MLSS Reports Strong Revenue Growth in Medical Segment - GuruFocus
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY - The Manila Times
Milestone Scientific's preliminary Q2 revenue rises on base business expansion - TradingView
Milestone Scientific's medical segment posts 300% growth as revenue climbs - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Price to earnings forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Enterprise value to revenue forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Enterprise value to EBIT forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Enterprise value to EBITDA forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
Milestone Scientific Inc. Actuals & Estimates (AMEX:MLSS) - TradingView
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Milestone Scientific Inc (MLSS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MLSS Forecast — Price Target — Prediction for 2027 - TradingView
Milestone Scientific Inc. Announces Board Changes - marketscreener.com
Milestone Scientific adds two directors, transitions board chair By Investing.com - Investing.com Nigeria
Milestone Scientific Strengthens Board with Healthcare and Finance Experts to Drive Strategic Growth - Minichart
Milestone Scientific adds two directors, transitions board chair - Investing.com
Milestone Scientific Restructures Leadership and Governance Agreements - TipRanks
Milestone Scientific (MLSS) revamps board, names Executive Chair and restructures founder deal - Stock Titan
Press Release: Milestone Scientific Strengthens Board to Support Next Phase of Growth - Moomoo
Milestone Scientific Inc (MLSS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Milestone Scientific Inc (MLSS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form DEF 14A Milestone Scientific Inc. For: 22 June By Investing.com - Investing.com South Africa
[DEF 14A] MILESTONE SCIENTIFIC INC. Definitive Proxy Statement - Stock Titan
Milestone Scientific (MLSS) Surges 9.24% as Shares Approach ResistanceInsider Selling Alerts - dars.gov.et
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Institutional Confidence - TradingKey
Milestone Scientific Inc (MLSS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive SurpriseBalance Sheet Strength - newsline.com
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareBook Value Growth - newsline.com
SpaceX Shares Surge 11% in Nasdaq Debut After Landmark $75 Billion IPOPreliminary Results - newsline.com
NASA’s experimental quiet supersonic plane passes another critical milestone - Scientific American
Space explorationMilestones, Achievements, History - Encyclopedia Britannica
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherROA Comparison - newsline.com
Milestone Scientific (MLSS) asks shareholders to expand share authorization and equity plan - Stock Titan
[EFFECT] MILESTONE SCIENTIFIC INC. SEC Filing - Stock Titan
World Dental Anesthesia Delivery SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Milestone Scientific (MLSS) registers 15.9M shares; warrants exercisable at $0.3375 - Stock Titan
Milestone Scientific (MLSS) asks shareholders to increase authorized shares and equity plan - Stock Titan
DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal - Yahoo Finance
Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com
MLSS: Selling Stockholder to Offer Nearly 8 Million Shares - GuruFocus
Milestone Scientific (NYSE American: MLSS) registers 15.9M shares from April 2026 placement - Stock Titan
Milestone Scientific Inc. Azioni (MLSS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Milestone Scientific Inc. Azioni (MLSS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BP4 S.r.l. | 10% Owner |
Oct 23 '25 |
Sale |
0.43 |
80,000 |
34,416 |
8,996,765 |
| BP4 S.r.l. | 10% Owner |
Oct 22 '25 |
Sale |
0.45 |
14,427 |
6,488 |
9,076,765 |
| BP4 S.r.l. | 10% Owner |
Oct 21 '25 |
Sale |
0.44 |
40,000 |
17,592 |
9,091,192 |
| BP4 S.r.l. | 10% Owner |
Oct 20 '25 |
Sale |
0.45 |
24,034 |
10,880 |
9,131,192 |
| BP4 S.r.l. | 10% Owner |
Oct 14 '25 |
Sale |
0.54 |
30,000 |
16,185 |
9,155,226 |
| BP4 S.r.l. | 10% Owner |
Oct 10 '25 |
Sale |
0.55 |
10,158 |
5,588 |
9,185,226 |
| BP4 S.r.l. | 10% Owner |
Oct 13 '25 |
Sale |
0.55 |
10,000 |
5,500 |
9,175,226 |
| BP4 S.r.l. | 10% Owner |
Oct 08 '25 |
Sale |
0.47 |
30,000 |
13,950 |
9,195,384 |
| BP4 S.r.l. | 10% Owner |
Oct 07 '25 |
Sale |
0.45 |
10,000 |
4,500 |
9,225,384 |
| BP4 S.r.l. | 10% Owner |
Oct 03 '25 |
Sale |
0.45 |
19,210 |
8,636 |
9,235,384 |
2.39%
2.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):